Cargando…
The Potential for Targeting AVIL and Other Actin-Binding Proteins in Rhabdomyosarcoma
Rhabdomyosarcoma (RMS) is the most common pediatric soft-tissue cancer with a survival rate below 27% for high-risk children despite aggressive multi-modal therapeutic interventions. After decades of research, no targeted therapies are currently available. Therapeutically targeting actin-binding pro...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531751/ https://www.ncbi.nlm.nih.gov/pubmed/37762498 http://dx.doi.org/10.3390/ijms241814196 |